Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.59 USD | -4.40% | -7.12% | -15.04% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.04% | 69Cr | |
+10.19% | 12TCr | |
+10.22% | 11TCr | |
-11.73% | 2.34TCr | |
-1.69% | 2.21TCr | |
-10.23% | 1.83TCr | |
-41.92% | 1.66TCr | |
-15.98% | 1.6TCr | |
+6.84% | 1.4TCr | |
+18.34% | 1.17TCr |
- Stock Market
- Equities
- ALXO Stock
- News ALX Oncology Holdings Inc.
- ALX Oncology Doses First Patient in Phase 2/3 Trial of Evorpacept in Gastric, Gastroesophageal Junction Cancer